Results 161 to 170 of about 285,368 (185)

Pharmacogenetic Implications for Antidepressant Therapy in Major Depression: A Systematic Review Covering 2019-2024. [PDF]

J Clin Med
Fornaguera A, Miarons M.
europepmc   +1 more source

Antidepressant use and all-cause mortality in depressed individuals: A real-world cohort study. [PDF]

PLoS One
Zhou S, Wang C, Zhang Y.
europepmc   +1 more source

Clinical burden of major depressive disorder with versus without prominent anhedonia using a real-world electronic health records and claims linked database. [PDF]

BMC Psychiatry
Kale H, Severtson SG, Feldman BS, Drissen T, Dwibedi N, Cutler AJ, Marci CD.   +6 more
europepmc   +1 more source

Protective Effects of <i>Curcuma longa L</i>. on Corticosterone-Induced Neurotoxicity and Anti-Depression-Like Behavior: Involvement of NMDA and 5-HT_7A Receptors. [PDF]

J Microbiol Biotechnol
Oh KN, Oh DR, Kim Y, Kim S.
europepmc   +1 more source

Depression, antidepressant use, and breast cancer incidence: results from the E3N prospective cohort. [PDF]

Psychiatry Clin Neurosci
Colle R, Deflesselle E, Mohamed O, Falissard B, Severi G, Fournier A, Boutron-Ruault MC, Corruble E.   +7 more
europepmc   +1 more source

Association of Blood Cell-Derived Inflammatory Markers with Symptoms and Short-Term Treatment Response in Late-Life Depression. [PDF]

Neuropsychiatr Dis Treat
Lu M, Zhang Y, Shi L, Wang Q, Yang X, Ma H, Wang M, Zhao Y, Miao Q.   +8 more
europepmc   +1 more source

Key informant perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care in Ontario, Canada: a qualitative description study. [PDF]

BMJ Open
Cernat A, Abelson J, Samaan Z, Ramdyal A, Vanstone M.   +4 more
europepmc   +1 more source